Skip to main content
Clinical Trials/NCT01710761
NCT01710761UnknownNot Applicable

Effects of Neo40(TM) With Caffeine on Cycling Time Trial Performance

University of Texas at Austin1 site in 1 country16 target enrollmentStarted: October 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
16
Locations
1
Primary Endpoint
Improved Time Trial Performance

Study Overview

Brief Summary

Acute supplementation of Neo40(TM), a nitrate lozenge, will improve cycling performance

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
21 Years to 49 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Regular commuter cyclist or spin class participant
  • •Male (VO2max < 50) or Female (VO2max < 45)
  • •Blood pressure below 140/90
  • •Non-smoker

Exclusion Criteria

  • •Does not cycle 2-3 times/week
  • •Regular consumption of performance-enhancing substances
  • •Type I or Type II diabetes
  • •Renal, hepatic or cardiac disease
  • •Current infectious disease

Arms & Interventions

Nitrate supplement with caffeine

Active Comparator

Intervention: Nitrate supplement with caffeine (Dietary Supplement)

Placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Outcomes

Primary Outcomes

Improved Time Trial Performance

Time Frame: After 20 min steady-state cycling

Participants will cycle 20 min at increasing intensity: 8 min at 55% VO2max, 6 min at 65% VO2max, 6 min at 75% VO2max. The 20 km time trial consists of rolling hills.

Secondary Outcomes

  • Improved work efficiency(During 20 min steady-state cycling)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials